K Pharma,Inc. Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-990	-844	301	-	-
Loss (Gain) From Sale of Assets	69	7	43	-	-
Other Operating Activities	-	-41	-1	-	-
Change in Inventory	-5	5	-	-	-
Change in Accounts Payable	-1	-1	1	-	-
Change in Other Net Operating Assets	9	-109	110	-	-
Operating Cash Flow	-918	-983	454	-	-
Capital Expenditures	-11	-14	-9	-	-
Other Investing Activities	-43	-	-2	-	-
Investing Cash Flow	-54	-14	-11	-	-
Long-Term Debt Issued	1,495	-	-	-	-
Net Debt Issued (Repaid)	1,495	-	-	-	-
Issuance of Common Stock	-	-	1,496	-	-
Other Financing Activities	1	-	-10	-	-
Financing Cash Flow	1,496	-	1,486	-	-
Miscellaneous Cash Flow Adjustments	-1	-1	-	-	-
Net Cash Flow	523	-998	1,929	-	-
Free Cash Flow	-929	-997	445	-	-
Free Cash Flow Margin	-	-	44.50%	-	-
Free Cash Flow Per Share	-80.05	-85.91	39.48	-	-
Cash Income Tax Paid	1	41	1	-	-
Levered Free Cash Flow	-568.88	-689.5	357.38	-	-
Unlevered Free Cash Flow	-564.5	-689.5	357.38	-	-
Change in Working Capital	3	-105	111	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.